Palatin Technologies Inc (LTS:0KF3)
$ 1.1216 0.0122 (1.1%) Market Cap: 22.48 Mil Enterprise Value: 20.57 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Palatin Technologies Inc Vyleesi Update Call Transcript

Jul 27, 2020 / 12:30PM GMT
Release Date Price: $13.25
Operator

Ladies and gentlemen, good morning, and welcome to the Palatin Technologies conference call to discuss the return of Vyleesi, Palatin's FDA-approved treatment for HSDD. As a reminder, this conference is being recorded.

Before we begin our remarks, I would like to remind you that statements made by Palatin that are not historical facts may be forward-looking statements. These statements are based on assumptions that may or may not prove to be accurate, and actual results may differ materially from those anticipated due to a variety of risks and uncertainties discussed in the company's most recent filings with the Securities and Exchange Commission. Please consider such risks and uncertainties carefully in evaluating these forward-looking statements and Palatin's prospects.

Now I'd like to turn the call over to today's host, Dr. Carl Spana, President and Chief Executive Officer of Palatin Technologies. Please go ahead, sir.

Carl Spana
Palatin Technologies, Inc. - Co-Founder, President, CEO & Director

Thank you. Good morning and welcome to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot